ABBOTT LABORATORIES
Explore this company’s associated devices, FDA decisions and regulatory history.

ABBOTT LABORATORIES
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name ABBOTT LABORATORIES. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Sep 23, 2026 to Sep 23, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MZO appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 100 Abbott Park Rd., Cp1, Abbott Park, IL, 60064, US. Recorded on K262156, decision dated Sep 23, 2026.
Device categories in this collection
Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Anti-HCV NextK262156 | ABBOTT LABORATORIES | 510(k) clearance | Sep 23, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 19, 2026.
